Institutional Preparedness

Because gene therapies represent a relatively new therapeutic class of agents, it is important that your institution considers the policies, training, and other aspects that would need to be in place prior to administering these agents. We asked pharmacy professionals with experience in introducing gene therapy into their institutions to provide their insights into the key considerations for preparing their institutions to administer gene therapies

kolland05.svg

Please see the following topics to explore the corresponding questions, and watch short videos of the experts’ detailed answers:



kolland02b.svg